Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Additive effect of DIMS spectacles to low-dose atropine for myopia control in children
TCTR20251209014Phase 4Recruiting
- Sponsor
- Ratchadaphiseksomphot Endowment Fund
- Start
- Sep 2024
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of atropine in myopia, sponsored by Ratchadaphiseksomphot Endowment Fund. Started Sep 2024; status: recruiting.
02
Drugs
atropine
03
Conditions
myopia
Beyond the preview
Go deeper on TCTR20251209014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20251209014.